Showing 151-160 of 5643 results for "".
Clinical Care Delivery: Tips for the Young Optometrist
https://modernod.com/topics/business/clinical-care-delivery-tips-for-the-young-optometrist/38167/Stay curious, stay flexible, and form strong relationships.A Place for House Calls in Optometry
https://modernod.com/topics/patient-care/a-place-for-house-calls-in-optometry/38789/Consider delivering eye care where it’s needed most.Correcting High Myopia at the Nodal Point
https://modernod.com/mod-issues/2022-oct/correcting-high-myopia-at-the-nodal-point/39127/Redesigned with a central port, the latest version of the ICL is associated with better visual outcomes and less risk than earlier iterations of the lens.Understanding the Genetics Behind Glaucoma
https://modernod.com/topics/glaucoma/understanding-the-genetics-behind-glaucoma/38741/The prevalence of different disease subtypes varies by ethnicity, suggesting a potential genetic component at play.The Role of Artificial Intelligence in Detecting Diabetic Retinopathy
https://modernod.com/mod-issues/2019-nov-dec/the-role-of-artificial-intelligence-in-detecting-diabetic-retinopathy/39094/A look at the technology’s potential to diagnose disease earlier and help to prevent blindness.Alcon Announces Plans to Acquire Lensar
https://modernod.com/podcasts/eyewire-news-the-podcast/alcon-announces-plans-to-acquire-lensar/37077/Alcon makes a major acquisition to bolster its cataract surgery portfolio; Opthea releases phase results for its combination wet AMD candidate; and Bausch + Lomb announces results from a phase 4 extension study of dry eye disease drug Miebo. Learn more about your ad choices. Visit megaphone.fm/adchoA Double-Header: Dry Eye and Filamentary Keratitis
https://modernod.com/mod-issues/2022-mar/a-double-header-dry-eye-and-filamentary-keratitis/38396/This case shows how dehydrated human amniotic membrane can be an effective treatment option for patients with both conditions.Ushering in a New Treatment Paradigm for Glaucoma: Updates on Novel Therapeutics and Disease-Modifying Treatments
https://modernod.com/topics/glaucoma/ushering-in-a-new-treatment-paradigm-for-glaucoma-updates-on-novel-therapeutics-and-disease-modifying-treatments/38079/Preserving Vision in Patients With Keratoconus
https://modernod.com/mod-issues/2022-jan-feb/preserving-vision-in-patients-with-keratoconus/38371/As protocols for diagnosis and management evolve, early detection and treatment can help to protect your patients’ vision.Long-Awaited Treatment for Demodex Blepharitis Receives FDA Approval
https://modernod.com/topics/ocular-surface/long-awaited-treatment-for-emdemodexem-blepharitis-receives-fda-approval/38645/The twice-daily prescription drop will be available by end of August 2023.